Molecular predictors in the early diagnosis of oral cancer

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 5, 2013, Pages 942-944

  Rajkumari, S ^a   Sathiyajeeva, J ^b   Santhosh Kumar, C ^c   Sunil, P M ^d   Thayumanavan, B ^a  

^a SATHYABAMA UNIVERSITY   (India)

^b Thai Moogambigai Dental College and Hospital   (India)

^c Sri Ramakrishna Dental College and Hospital   (India)

^d ANNAMALAI UNIVERSITY   (India)

Author keywords

Cancer; Growth factors; Loss of heterozygosity; Molecular changes; Telomerase; Tumor suppressor genes

Indexed keywords

ALPHAVBETA6 INTEGRIN; BLOOD GROUP ANTIGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; INTERSTITIAL COLLAGENASE; MITOCHONDRIAL DNA; PROTEIN BAX; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

BAX GENE; BCL 2 GENE; CANCER PROGNOSIS; CYTOSKELETON; DNA METHYLATION; DNA POLYMORPHISM; EARLY DIAGNOSIS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MOUTH CANCER; PROTEIN EXPRESSION; REVIEW; SURVIVAL PREDICTION;

EID: 84877127855     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5058.2983     Document Type: Review

References (17)

1. Sunil PM, Isaac Joseph, Soma Susan Varghese. Gene Therapy In Oral Squamous Cell Carcinoma - A Short Review. Oral and Maxillofacial Pathology Journal. 2011; 2 (2):142-47.
2. Siddiq M Ahmed, Mubeen, Jignab VR. Review Article Molecular biology: an early detector of oral cancers. Annals of Diagnostic Pathology. 2009;13:140-45.
3. Masthan K.MK., Rajkumari S, Deepasree M, Aravindha Babu N, Leena Sankari S. Neoplasms associated with odontogenic cysts. Journal of Dentistry and Oral Hygiene. 2011;3(10):123-30.
4. Sudbo, Reith. Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals. J Oral Pathol Med. 2003: 32; 63-70.
5. Michael Brennan, Cesar A Migliorati, Peter B Lockhart et al., Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol. Oral Radiol Endod. 2007;103:S19.e1-S19.e12
6. Rajakishore Mishra. Biomarkers of oral premalignant epithelial lesions for clinical application. Oral Oncology. 2012;48:578-84.
7. Chad A Glazer, Steven S Chang, Patrick K Ha, Joseph A Califano. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncology. 2009;45:440-46.
8. Scully C, Burkhardt A. Tissue markers of potential malignant human oral epithelial lesions. J oral pathol med. 1993;22:246-56.
9. Dong M. Shin, Walter N. Hittelman, Waun K. Hong. Biomarkers in Upper Aerodigestive Tract Tumorigenesis: A Review. Cancer Epidemiology, Biomarkers & Prevention. 1994; 3:697-709.
10. Vigneswaran N, Beckers S, Waigel S, Mensah J, Wu J, Mo J, et al., Increased EMMPRIN (CD147) expression during oral carcinogenesis. Exp Mol Pathol. 2006;80:147-59.
11. Soma Susan Varghese, Sunil P.M, Nirmal Madhavan R. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: An immunohistochemical study. Cancer Biomarkers. 2011;8:155-60.
12. Patrick K Ha, Steven S Chang, Chad A Glazer, Joseph A Califano, David Sidransky. Review Molecular techniques and genetic alterations in head and neck cancer. Oral Oncology. 2009;45:335-39.
13. Sharada S Sawant, Surekha M Zingde, Milind M Vaidya. Cytokeratin fragments in the serum: Their utility for the management of oral cancer. Oral Oncology. 2008;44:722-32.
14. Thomas G J, Jones J, Speight PM. Reviews Integrins and Oral Cancer. Oral Oncology. 1997;33(6):381-88.
15. Jesper Rebiel. Prognosis of oral premalignant lesions significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47-62.
16. Juan Seoane Lestón, Pedro Diz Dioshas. Diagnostic clinical aids in oral cancer. Oral Oncology. 2010;46:418-22.
17. Yi-Tien Liu, Li-Wen Lin, Chih-Yu Chen, Chao-Ping Wang, Han-Pang Liu, Jer-Yiing Houng, et al., Polymorphism of angiotensin I-converting enzyme gene is related to oral cancer and lymph node metastasis in male betel quid chewers. Oral Oncology. 2012; 48:1257-62.